Obstetric and Gynecologic Imaging

What Is the First Imaging Step for a Low-Risk Fetal Growth Disturbance?

·
What Is the First Imaging Step for a Low-Risk Fetal Growth Disturbance?

A 34-year-old G2P1 patient at 31 weeks gestation presents for a routine prenatal visit. Her pregnancy has been uncomplicated, with no significant medical history. On examination, her fundal height measures 28 centimeters, lagging the expected 31 weeks. This discrepancy raises the clinical question of a potential fetal growth disturbance. While she has no overt risk factors for fetal growth restriction (FGR), the clinical finding warrants further investigation. What is the appropriate initial imaging study to order in this common, low-risk scenario? According to the American College of Radiology (ACR) Appropriateness Criteria, a `US pregnant uterus transabdominal` is Usually Appropriate for the initial evaluation.

Who Fits This Clinical Scenario for Suspected Fetal Growth Disturbance?

This guidance applies specifically to pregnant patients where a growth disturbance is first suspected, but the overall risk for fetal growth restriction is low. The key trigger is often a clinical finding, most commonly a fundal height measurement that is smaller than expected for the gestational age (typically a discrepancy of 3 or more centimeters).

Inclusion criteria for this scenario:

  • A singleton pregnancy.
  • A clinical suspicion of a growth problem (e.g., lagging fundal height).
  • No major maternal or fetal risk factors for FGR. This includes the absence of conditions like chronic hypertension, pregestational diabetes, renal disease, autoimmune disorders (e.g., lupus), known placental abnormalities, or a prior history of delivering a growth-restricted infant.

It is crucial to distinguish this low-risk initial evaluation from other, similar-sounding clinical situations that follow different diagnostic pathways. This workflow does not apply to:

  • Patients with high-risk factors: A patient with preeclampsia, known maternal vascular disease, or carrying multiple gestations falls into the “Growth disturbance. High risk for fetal growth restriction. Initial evaluation” scenario, which may involve a more comprehensive initial assessment.
  • Patients with a known diagnosis: If a prior ultrasound has already established the diagnosis of FGR (estimated fetal weight <10th percentile), the patient's management shifts to surveillance, which is covered under the "Established fetal growth restriction. Follow-up evaluation" scenario.

Correctly identifying the patient as low-risk is the essential first step in applying this evidence-based workflow.

What Diagnoses Are You Working Up in This Low-Risk Scenario?

When a low-risk patient presents with a size-date discrepancy, the goal of imaging is to differentiate between benign variations and clinically significant pathology. The differential diagnosis guides the interpretation of the ultrasound findings.

The most common and reassuring explanation is a constitutionally small fetus. Just as adults vary in size, so do fetuses. A constitutionally small fetus is healthy, growing appropriately along its own genetic curve, and is simply smaller than the population average. An ultrasound can provide reassurance by demonstrating an estimated fetal weight (EFW) above the 10th percentile, normal anatomy, and adequate amniotic fluid.

Another possibility is inaccurate gestational dating. If the pregnancy was not dated with a first-trimester ultrasound, the last menstrual period (LMP) may be an unreliable estimator of gestational age. A fundal height that seems small for an LMP-based date may be perfectly appropriate for the actual, sonographically-determined gestational age. The initial ultrasound is the definitive tool for confirming or correcting the estimated due date.

A less common but important consideration is isolated oligohydramnios (low amniotic fluid). The volume of amniotic fluid contributes to the size of the uterus, and low fluid can cause the fundal height to measure small even if the fetus is appropriately grown. Ultrasound provides a direct and accurate assessment of amniotic fluid volume via the Amniotic Fluid Index (AFI) or Maximum Vertical Pocket (MVP).

Finally, the most consequential diagnosis to exclude is true fetal growth restriction (FGR). Even without pre-existing risk factors, a subset of patients can develop placental insufficiency during pregnancy, leading to impaired fetal growth. The initial ultrasound serves as a critical screening test to identify fetuses with an EFW below the 10th percentile, which would prompt a change in management and increased surveillance.

Why Is Transabdominal Ultrasound the Recommended Initial Study for a Low-Risk Growth Concern?

The ACR rates `US pregnant uterus transabdominal` as Usually Appropriate for this initial evaluation because it is the most direct, safest, and most effective tool to address the key clinical questions. This non-invasive study uses sound waves, not ionizing radiation (0 mSv), posing no risk to the mother or fetus. Its primary purpose in this context is to perform fetal biometry.

A standard growth ultrasound involves measuring the biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), and femur length (FL). These measurements are entered into established formulas to calculate an Estimated Fetal Weight (EFW), which is then plotted on a growth chart to determine its percentile for the given gestational age. This single examination directly differentiates a constitutionally small but healthy fetus (EFW >10th percentile) from a potentially growth-restricted one (EFW <10th percentile). The ultrasound also provides essential complementary information, including an assessment of amniotic fluid volume, placental location, and a basic anatomic survey. For this specific scenario—an initial, low-risk evaluation—more advanced studies are deemed Usually Not Appropriate.

  • US duplex Doppler fetal umbilical artery: This study assesses blood flow through the umbilical cord and is a critical tool for monitoring pregnancies complicated by established FGR. However, in an initial low-risk workup, it is not the primary diagnostic test. If the EFW is normal, the Doppler findings are unlikely to change management. It is a surveillance tool, not a first-line screening test for growth.
  • US pregnant uterus biophysical profile (BPP): A BPP evaluates markers of acute fetal well-being, such as fetal movement, tone, and breathing. It is a test of current fetal status, not a diagnostic tool for a chronic growth problem. It becomes relevant for fetal surveillance after a high-risk condition like FGR has been diagnosed.

When ordering the study, it is helpful to specify the indication, such as “size less than dates,” and to request “fetal biometry for EFW and amniotic fluid assessment.” This ensures the sonographer and radiologist perform the correct measurements to answer the clinical question.

What’s Next After the Ultrasound? Downstream Clinical Workflow

The results of the transabdominal ultrasound create a clear decision point in the patient’s management plan. The downstream workflow depends directly on whether the findings are reassuring or concerning.

  • If the study is normal: A normal result is defined as an EFW greater than the 10th percentile for gestational age with normal amniotic fluid volume. This finding is highly reassuring and suggests the initial clinical concern was likely due to a constitutionally small fetus or simple measurement variability. The patient can typically return to routine prenatal care. Some clinicians may opt for a single follow-up growth scan in 3 to 4 weeks to confirm a normal interval growth velocity, which provides definitive evidence of a healthy, constitutionally small fetus.
  • If the study is abnormal (EFW <10th percentile): This result establishes the diagnosis of fetal growth restriction. The patient’s risk status immediately changes from low to high. Management should be escalated, often involving consultation with a Maternal-Fetal Medicine (MFM) specialist. The next steps transition from diagnosis to surveillance and are guided by the “Established fetal growth restriction. Follow-up evaluation” ACR variant. This typically involves serial growth ultrasounds every 3-4 weeks and initiating fetal surveillance with Doppler studies (e.g., umbilical artery Doppler) and/or biophysical profiles to monitor fetal well-being.
  • If the study is indeterminate: In some cases, the EFW may be borderline (e.g., 10th-15th percentile) or there may be isolated oligohydramnios with a normal-sized fetus. This warrants closer observation. The most appropriate next step is typically a follow-up ultrasound in 2 to 3 weeks to assess interval growth and re-evaluate fluid. A clear slowing of growth velocity on the follow-up scan would be concerning and prompt reclassification to FGR.

Pitfalls to Avoid (and When to Get Help)

In this seemingly straightforward workup, several pitfalls can lead to diagnostic confusion or inappropriate management.

First, avoid relying on a single fundal height measurement. A single data point can be misleading due to patient body habitus, fetal position, or inter-observer variability. A trend of lagging growth over several visits is a more reliable indicator. Second, do not order advanced testing like Doppler studies or a biophysical profile for the initial workup of a low-risk patient; this can lead to unnecessary patient anxiety and healthcare costs without changing initial management. Third, ensure the gestational age is accurate. Applying growth percentiles based on an incorrect due date is a common source of error.

Finally, a critical pitfall is failing to act on an abnormal result. An EFW below the 10th percentile is not a “wait and see” situation. If the initial ultrasound confirms FGR, the patient’s care plan must be escalated promptly to include increased surveillance and specialist consultation to optimize neonatal outcomes.

Related ACR Topics and Tools

For a comprehensive overview of imaging across all related clinical presentations, refer to the parent topic guide. Additional GigHz tools can help you navigate adjacent scenarios and understand the technical aspects of the recommended imaging.

Frequently Asked Questions

How much of a fundal height discrepancy should prompt an ultrasound?

A common threshold used in clinical practice is a discrepancy of 3 or more centimeters between the fundal height measurement and the weeks of gestation. However, any persistent lag in growth or a static measurement over several weeks can be an indication for an initial ultrasound evaluation, even if the discrepancy is smaller.

If the ultrasound shows an Estimated Fetal Weight (EFW) at the 12th percentile, what is the next step?

An EFW at the 12th percentile is considered appropriate for gestational age (AGA), as it is above the 10th percentile cutoff for Fetal Growth Restriction (FGR). This is a reassuring finding. The most common next step is to continue routine prenatal care, with consideration for a follow-up growth scan in 3-4 weeks to confirm a stable growth trajectory.

Why aren’t Doppler studies recommended for this initial low-risk evaluation?

Umbilical artery Doppler studies are a tool for surveillance and risk stratification in cases of *established* FGR. In an initial, low-risk patient, the primary goal is to determine if the fetus is small (i.e., to diagnose FGR). If the EFW is normal, Doppler findings are very unlikely to be abnormal or to change management. They are therefore considered ‘Usually Not Appropriate’ as a first-line screening tool in this specific scenario.

Can a transvaginal ultrasound be used for this evaluation?

A transvaginal ultrasound is generally not the primary tool for assessing fetal growth in the second or third trimester. Fetal biometry measurements (head, abdomen, femur) are best obtained via a transabdominal approach. A transvaginal scan may be used as an adjunct to better evaluate the cervix or placenta if it is low-lying, but it is not the standard method for calculating the EFW.

What if the patient is low-risk but has a history of a prior pregnancy with FGR?

A history of FGR in a prior pregnancy automatically moves the patient into a higher-risk category for the current pregnancy. This clinical scenario would no longer be considered ‘low risk.’ The patient would fit into the ‘Growth disturbance. High risk for fetal growth restriction. Initial evaluation’ variant, which may involve a different schedule of screening and surveillance ultrasounds.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026